- Posted
- Categories
-
- OpenPrescribing
OpenPrescribing Newsletter: Autumn 2026
Upcoming webinars, new inhaler and hospital prescribing measures, and finalised hospital medicines data through March 2026.
Monthly newsletters about data updates and new features
Upcoming webinars, new inhaler and hospital prescribing measures, and finalised hospital medicines data through March 2026.
Rebuilding OpenPrescribing, a measures advisory group, hospital trust dashboards, an FP10 viewer, and new morphine and hospital measures.
Shareable hospital analyses, email alerts, dapagliflozin and insulin detemir measures, and OpenSAFELY’s expansion beyond COVID-19 research.
The Bennett Symposium and Prize, multiproduct hospital analyses, and new measures for low-value prescribing, dapagliflozin and AWaRe antibiotics.
Special edition OpenPrescribing newsletter introducing our new tool, OpenPrescribing Hospitals.
An updated best-value DOAC measure, developments in hospital medicines data, webinar recordings, and an analysis of OpenPrescribing’s users.
Free OpenPrescribing webinars, plans to phase out STAR-PUs, and updates to the excess pen quantities measure and price concession calculations.
Debating STAR-PUs, launching Improvement Radar to identify prescribing improvements, and research on medication reviews during COVID-19.
Why prescribing analyses differ between platforms, a BNF-to-dm+d map, and updates to antibiotic and glucose test strip measures.
NHS medicines optimisation tools, an investigation into rising colesevelam costs, and a look at the pharmacists behind OpenPrescribing.
The launch of the Bennett Institute, the Goldacre Review, live Outlier Detection Dashboards, and new measures for DOACs and inhaler carbon footprints.
Previewing the Outlier Prescribing tool, updating measures and maps, and research on antidepressant prescribing and anticoagulant safety.
Retiring the hospital-only measure, updating oral morphine equivalence, introducing OpenCodelists, and reporting COVID-19 vaccine coverage.
New hospital medicines data, plans for OpenPrescribing Hospitals, research on clinical software design, and an oral morphine equivalence update.
New papers on hospital medicines data, NHS analytics and statin prescribing, alongside updated CCG dashboards and OpenSAFELY COVID-19 research.
New research on unsafe methotrexate prescribing, bespoke prescribing email alerts, and analysis of COVID-19’s impact on prescribing in March 2020.
Introducing OpenSAFELY, COVID-19’s early impact on prescribing, rising price concession costs, and bespoke PCN email alerts.
PCN dashboards go live, research examines clinical software and prescribing safety, and a guest blog explores high-dose dexamethasone.
New inhaler environmental impact and seven-day prescribing measures, research on prescribing changes, and expanded data downloads.
Links from prescribing measures to the Analyse page, improvements to the price-per-unit savings tool, and preparations for PCN dashboards.
The launch of the NHS dm+d browser, lower thresholds for price-per-unit savings, and price concession dashboards for STPs and regional teams.
New low-priority prescribing measures and All England email alerts, alongside Analyse page improvements and plans for Primary Care Network dashboards.
Research on variation in adopting UTI prescribing guidance, user testing for regional and STP dashboards, and preparations for newly merged CCGs.
New price concession email alerts, a guide to finding prescribing cost savings, and improvements to measure breakdowns and Analyse page totals.
New measures for NHS England’s proposed do-not-prescribe list, a planned price concessions calculator, and prescribing data limitations.
The launch of the All England dashboard, support for responding to phenytoin supply disruption, and tools for antimicrobial stewardship.
How OpenPrescribing’s alerts detect changes before practices become extreme outliers, plus new category filters for prescribing measures.
New research examines pregabalin patent litigation and Lyrica prescribing, alongside site improvements that flag closed or dormant practices.
Research on low-priority prescribing, 2017 data in the Long Term Trends tool, and a call for measures highlighting easy prescribing improvements.
New research on homeopathy and gluten-free prescribing, plus tips for using the Analyse page to investigate prescribing variation and trends.
An update on medicine price concessions, preparations for CCG mergers, and early work on OpenPathology to explore NHS blood test use.
A new opioid measure using oral morphine equivalents, improvements to the Long Term Trends tool, and the launch of the FDAAA TrialsTracker.
The continuing cost of generic medicine price concessions, variation in gluten-free food prescribing, and a guide to OpenPrescribing’s features.
Analyse prescribing without a denominator, explore a new pregabalin measure based on milligrams, and use improved three-month measure breakdowns.
Explore prescribing trends from 1998 to 2016 with the new Long Term Trends tool, alongside an updated pregabalin measure based on prescription items.
New measures track NHS England’s low-priority treatments, while drug-level breakdowns help practices and CCGs investigate prescribing variation.